66306-10-3

Basic information

• Product Name: Benzoyl chloride, 2-hydroxy-3,5-dinitro-
• Synonyms: Benzoyl chloride, 2-hydroxy-3,5-dinitro-
• CAS NO: 66306-10-3
• Molecular Formula: C₇H₃ClN₂O₆
• Molecular Weight: 246.56152
• EINECS: -0
• Mol File: 66306-10-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoyl chloride, 2-hydroxy-3,5-dinitro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoyl chloride, 2-hydroxy-3,5-dinitro-(66306-10-3)
• EPA Substance Registry System: Benzoyl chloride, 2-hydroxy-3,5-dinitro-(66306-10-3)

Safety Data

• Hazardous Substances Data: 66306-10-3(Hazardous Substances Data)

Upstream product

• 10026-13-8 phosphorus pentachloride 
• 609-99-4 3,5-dinitrosalicylic acid 

Downstream Products

• 227946-85-2 C₁₅H₂₁N₃O₆ 
• 227946-84-1 C₁₅H₁₃N₃O₆ 
• 2912-79-0 2-hydroxy-3,5-dinitrobenzamide 
• 1415566-89-0 C₁₀H₅N₅O₈S 
• 215781-76-3 C₃₂H₂₄N₄O₁₄ 
• 125665-41-0 {2-Butyl-5-chloro-3-[4-(2-hydroxy-3,5-dinitro-benzoylamino)-benzyl]-3H-imidazol-4-yl}-acetic acid methyl ester 
• 22557-74-0 ethyl 3,5-dinitrosalicylate 
• 22633-33-6 methyl-3,5-dinitrosalicylate 

Relevant articles and documents

Evaluation of the anticancer properties of the predicted hBaxBH3-mimetic compound 2-hydroxy-3,5-dinitrobenzamide in a mammary carcinogenesis-induced rat model

Designing small molecular prototypes having potential to disrupt binding interfaces of pro-apoptotic-anti-apoptotic/BH3-only proteins is a promising strategy in cancer chemotherapy. Several natural and synthetic chemical compounds have been reported as in

Urea thiadiazole inhibitors of plasminogen activator inhibior-1

Methods of treating disorders associated with elevated levels of PAI-1 are disclosed comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of formula (I), or a pharmaceutically-acceptable salt, prodrug, stereoisomer or solvate thereof, wherein: A is aryl o heteroaryl, and R1-R12, are defined herein. The invention also pertains to pharmaceutical compositions and compounds within the scope of formula (I) as well as medicaments and articles of manufacture comprising compounds of formula (I).

Synthesis and Biological Activities of 1,1′-Bis(p-substituted-benzoyloxy-substituted-phenyl)cyclohexane

1,1′-Bis(p-substituted-benzoyloxy-substituted-phenyl)cyclohexane have been synthesized. Most of the compounds exhibit promising antibacterial activity and moderate anifungal activity.